Skip to main content
. 2013 Jul 9;57(8):1106–1113. doi: 10.1093/cid/cit454

Table 1.

Clinical Outcomes of Subjects After Challenge With Campylobacter jejuni CG8421

Outcome All Naive Veteran
No. 15 8
Met primary endpoint of campylobacteriosis, No. (%) 14 (93) 8 (100)
Any diarrhea, No. (%) 14 (93) 8 (100)
Severe diarrhea, No. (%) 8 (53) 7 (88)
Time in hoursto campylobacteriosis, median (IQR) 52.3 (46.9–56.1) 53.7 (48.3–73.7)
Time in hours to first diarrheal stool, median (IQR) 45.9 (43.7–51.2) 51.1 (37.0–67.3)
Number of diarrhea stools, grade 3–5, median (IQR) 14 (7–17) 13 (11–16)
Highest 24-h stool output number, grade 3–5, median (IQR) 7 (4–10) 8 (6–10)
Highest 24-h stool output volume, mL, grade 3–5, median (IQR) 661 (406–754) 710 (574–859)
Total diarrhea volume, mL, median (IQR) 1122 (493–1621) 1122 (900–1669)
Time in hours to first antibiotic dose, median (IQR) 57.0 (48.0–86.0) 58.1 (46.7–76.4)
Gastrointestinal symptoms, No. (%)
 Nausea 11 (73)a 2 (25)a
 Vomiting 0 (0.0) 1 (13)
 Abdominal pain/cramping, any 14 (93) 6 (75)
 Abdominal pain/cramping, severe 3 (20) 0 (0)
 Dysentery 02 (13.3) 1 (13)
Systemic symptoms, No. (%)
 Fever 8 (53) 2 (25)
 Headache 12 (80) 5 (63)
 Diarrheal disease Severity index,b median (range) 9.5 (01–14) 8 (4–11)

Abbreviation: IQR, interquartile range.

a No associations were statistically significant, except nausea. P = .04.

b See [8].